Chemoinformaics analysis of 1,4,7-EUDESMANETRIOL
| Molecular Weight | 256.386 | nRot | 1 |
| Heavy Atom Molecular Weight | 228.162 | nRig | 11 |
| Exact Molecular Weight | 256.204 | nRing | 2 |
| Solubility: LogS | -1.665 | nHRing | 0 |
| Solubility: LogP | 1.771 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 46 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 46.1262 |
| nHD | 3 | BPOL | 28.0898 |
| QED | 0.673 |
| Synth | 4.36 |
| Natural Product Likeliness | 2.869 |
| NR-PPAR-gamma | 0.013 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.016 |
| HIA | 0.013 |
| CACO-2 | -4.484 |
| MDCK | 0.0000208 |
| BBB | 0.955 |
| PPB | 0.481239 |
| VDSS | 1.296 |
| FU | 0.371309 |
| CYP1A2-inh | 0.017 |
| CYP1A2-sub | 0.302 |
| CYP2c19-inh | 0.014 |
| CYP2c19-sub | 0.857 |
| CYP2c9-inh | 0.031 |
| CYP2c9-sub | 0.302 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.252 |
| CYP3a4-inh | 0.066 |
| CYP3a4-sub | 0.242 |
| CL | 11.542 |
| T12 | 0.393 |
| hERG | 0.023 |
| Ames | 0.024 |
| ROA | 0.075 |
| SkinSen | 0.137 |
| Carcinogencity | 0.024 |
| EI | 0.059 |
| Respiratory | 0.092 |
| NR-Aromatase | 0.029 |
| Antiviral | Yes |
| Prediction | 0.863735 |